Company / SG&A Expense
Sagimet Biosciences Inc. SG&A Expense History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$13.0M
FY2024
5-year range
$6.1M / $13.0M
FY2023-FY2024
Trend
+111.3%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$13M in FY2024.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, sg&a expense increased 111.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score 0.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $13.0M | +111.3% |
| FY2023 | $6.1M | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026